BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Diagnosis
36 results:

  • 1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 2. The diagnosis and treatment for primary cardiac angiosarcoma with n-ras gene mutation and MSI-L: A case report and review of the literature.
    Sun J; Wei T; Sun B; Su J; Liu H; Wang D; Li X
    Medicine (Baltimore); 2023 Dec; 102(51):e36682. PubMed ID: 38134104
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characterization of 164 patients with nras mutated non-small cell lung cancer (NSCLC).
    Dehem A; Mazieres J; Chour A; Guisier F; Ferreira M; Boussageon M; Girard N; Moro-Sibilot D; Cadranel J; Zalcman G; Ricordel C; Wislez M; Munck C; Poulet C; Gauvain C; Descarpentries C; Wasielewski E; Cortot AB; Baldacci S
    Lung Cancer; 2023 Dec; 186():107393. PubMed ID: 37839252
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.
    Zhang Q; Sun Y; Wang C; Shao F
    Bioengineered; 2022 Mar; 13(3):6258-6271. PubMed ID: 35212617
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Monitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
    Ariyasu R; Uchibori K; Sasaki T; Tsukahara M; Kiyotani K; Yoshida R; Ono Y; Kitazono S; Ninomiya H; Ishikawa Y; Mizukami Y; Yanagitani N; Fujita N; Nishio M; Katayama R
    Cancer Sci; 2021 Jun; 112(6):2371-2380. PubMed ID: 33686722
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical significance of HRAS and KRAS genes expression in patients with non-small-cell lung cancer - preliminary findings.
    Pązik M; Michalska K; Żebrowska-Nawrocka M; Zawadzka I; Łochowski M; Balcerczak E
    BMC Cancer; 2021 Feb; 21(1):130. PubMed ID: 33549031
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dedifferentiated and Undifferentiated Melanomas: Report of 35 New Cases With Literature Review and Proposal of Diagnostic Criteria.
    Agaimy A; Stoehr R; Hornung A; Popp J; Erdmann M; Heinzerling L; Hartmann A
    Am J Surg Pathol; 2021 Feb; 45(2):240-254. PubMed ID: 33428337
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
    Shang Y; Li X; Liu W; Shi X; Yuan S; Huo R; Fang G; Han X; Zhang J; Wang K; Dou Z; Zhang Y; Zang A; Zhang L
    Sci Rep; 2020 Nov; 10(1):20243. PubMed ID: 33219256
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Giant lung metastasis of nras-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
    Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
    Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.
    Samà MT; Grosso E; Mele C; Laurora S; Monzeglio O; Marzullo P; Boldorini R; Aluffi Valletti P; Aimaretti G; Scatolini M; Pagano L
    Endocrine; 2021 Jan; 71(1):149-157. PubMed ID: 32621051
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Valencia-Sama I; Ladumor Y; Kee L; Adderley T; Christopher G; Robinson CM; Kano Y; Ohh M; Irwin MS
    Cancer Res; 2020 Aug; 80(16):3413-3423. PubMed ID: 32586982
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer.
    Roncarati R; Lupini L; Miotto E; Saccenti E; Mascetti S; Morandi L; Bassi C; Rasio D; Callegari E; Conti V; Rinaldi R; Lanza G; Gafà R; Papi A; Frassoldati A; Sabbioni S; Ravenna F; Casoni GL; Negrini M
    Mol Oncol; 2020 Sep; 14(9):2163-2175. PubMed ID: 32441866
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in cancer Diagnostics.
    Sonmezler O; Boga I; Bisgin A
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas.
    Campanella NC; Silva EC; Dix G; de Lima Vazquez F; Escremim de Paula F; Berardinelli GN; Balancin M; Chammas R; Mendoza Lopez RV; Silveira HCS; Capelozzi VL; Reis RM
    Pathobiology; 2020; 87(3):208-216. PubMed ID: 32369821
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
    Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA
    Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An nras mutation in primary malignant melanoma of the lung: a case report.
    Hibiya T; Tanaka M; Matsumura M; Aoki A; Ikegami T; Okudela K; Kawano N; Ohashi K
    Diagn Pathol; 2020 Feb; 15(1):11. PubMed ID: 32028967
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Survival and prognostic factors in surgically treated brain metastases.
    Kavouridis VK; Harary M; Hulsbergen AFC; Lo YT; Reardon DA; Aizer AA; Iorgulescu JB; Smith TR
    J Neurooncol; 2019 Jun; 143(2):359-367. PubMed ID: 30989623
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.
    Castiglione R; Alidousty C; Holz B; Wagener S; Baar T; Heydt C; Binot E; Zupp S; Kron A; Wolf J; Merkelbach-Bruse S; Reinhardt HC; Buettner R; Schultheis AM
    Mod Pathol; 2019 May; 32(5):627-638. PubMed ID: 30459450
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.